Brain Tumors

Pituitary Surgery

Survival: Pituitary Surgery

2016 – 2020

Both the 30- and 180-day survival rates following pituitary surgery were 100% for 2020.

Inpatient Mortality: Pituitary Surgery

2016 – 2020

ᵃThe 3M™ All Patient Refined Diagnosis Related Groups (APR-DRG) Classification System is used for adjusting data for severity of illness and risk of mortality.

There has been no surgical inpatient mortality following pituitary surgery for the past 5 years.

Average Length of Stay: Pituitary Surgery

2016 – 2020

LOS = length of stay

ᵃThe 3M™ All Patient Refined Diagnosis Related Groups (APR-DRG) Classification System is used for adjusting data for severity of illness and risk of mortality.

Following pituitary surgery, actual length of stay has been close to expected for the past 5 years.

Karnofsky Performance Status — Percent Change (N = 8)

2020

In 88% of patients, performance status either remained stable or improved after pituitary surgery. Functional status is measured by the Karnofsky Performance Scale (KPS), a widely used 11-point scale correlating to percentage values from 100% (no evidence of disease, no symptoms) to 0% (death). Change in KPS status was defined as a change of ≥ 20 points.